Effect of Mimosa pudica Extract on NF-κB Expression in Blastocystis sp. Inoculated Rats
DOI:
10.29303/jbt.v26i3.12339Published:
2026-07-28Downloads
Abstract
Blastocystis sp. is an intestinal protozoan capable of inducing intestinal inflammation through activation of the Nuclear Factor Kappa B (NF-κB) signaling pathway. Current treatment relies on metronidazole, although its efficacy is limited by variable therapeutic responses and adverse effects. Mimosa pudica contains bioactive compounds with potential antiprotozoal and anti-inflammatory activities. This study aimed to evaluate the effect of Mimosa pudica extract on NF-κB expression in Blastocystis sp.-infected Wistar rats. An experimental post-test control group design was conducted using 30 male Wistar rats randomly assigned to six groups: negative control, positive control, metronidazole (9 mg and 13.9 mg), and Mimosa pudica extract (40 mg and 80 mg). Rats were orally inoculated with 10⁵ Blastocystis sp., followed by treatment. Phytochemical screening and FTIR was performed, and NF-κB expression was analyzed using RT-PCR. Phytochemical analysis confirmed the presence of flavonoids, alkaloids, tannins, and saponins. Administration of Mimosa pudica extract reduced NF-κB expression compared with the positive control. A significant difference in NF-κB expression was observed among the study groups (p = 0.028). These findings suggest that Mimosa pudica extract exhibits antiprotozoal and anti-inflammatory activity and may serve as a potential complementary therapy for blastocystosis through modulation of the NF-κB signaling pathway.
Keywords:
Antiprozoal Blastocystis sp. Mimosa pudica extract NF-κBReferences
Abu, A. et al. (2023) ‘Prevalence and Subtype Distribution of Blastocystis Isolated from School-Aged Children in the Thai-Myanmar Border, Ratchaburi Province, Thailand’, International Journal of Environmental Research and Public Health, 20(1). Available at: https://doi.org/10.3390/ijerph20010204.
Adurosakin, O.E. et al. (2023) ‘Pharmacological Research - Modern Chinese Medicine Ethnomedicinal uses , phytochemistry , pharmacological activities and toxicological effects of Mimosa pudica - A review’, 7(February). Available at: https://doi.org/10.1016/j.prmcm.2023.100241.
Azam, S. et al. (2015) ‘Anti-inflammatory and anti-oxidant study of ethanolic extract of Mimosa pudica’, Journal of Young Pharmacists, 7(3), pp. 234–240. Available at: https://doi.org/10.5530/jyp.2015.3.14.
Bautista, E. et al. (2011) ‘Antiprotozoal activity of flavonoids isolated from Mimosa tenuiflora (Fabaceae-Mimosoideae)’, Journal of the Mexican Chemical Society, 55(4), pp. 251–253.
Chandramathi, S. et al. (2014) ‘Stress Exacerbates Infectivity and Pathogenicity of Blastocystis hominis : In Vitro and In Vivo Evidences’, 9(5), pp. 1–11. Available at: https://doi.org/10.1371/journal.pone.0094567.
Faturrahman, M.A. et al. (2024) ‘Studi Literatur: Aktivitas Farmakologis Putri Malu (Mimosa pudica L.)’, Jurnal Biogenerasi, 9(1), pp. 940–948.
Javanmard, E. et al. (2018) ‘Impacts of human development index and climate conditions on prevalence of Blastocystis: A systematic review and meta-analysis’, Acta Tropica, 185, pp. 193–203. Available at: https://doi.org/10.1016/j.actatropica.2018.05.014.
Jodynis-liebert, J. and Kujawska, M. (2020) ‘Biphasic Dose-Response Induced by Phytochemicals : Experimental Evidence’.
Karunita Ika Astuti, Fitriyanti and Nur Huda (2020) ‘Uji Aktivitas Antidiare Ekstrak Etanol 96% Herba Putri Malu (Mimosa pudica L.) Terhadap Mencit Jantan Yang Diinduksi Oleum ricini’, Borneo Journal of Pharmascientech, 4(1), pp. 42–50. Available at: https://doi.org/10.51817/bjp.v4i1.276.
Kosik-Bogacka, D. et al. (2021) ‘Prevalence, subtypes and risk factors of Blastocystis spp. infection among pre- and perimenopausal women’, BMC Infectious Diseases, 21(1), pp. 1–14. Available at: https://doi.org/10.1186/s12879-021-06815-z.
Kumarasamy, V. et al. (2018) ‘Blastocystis sp., Parasite Associated with Gastrointestinal Disorders: An Overview of its Pathogenesis, Immune Modulation and Therapeutic Strategies’, Current Pharmaceutical Design, 24(27), pp. 3172–3175. Available at: https://doi.org/10.2174/1381612824666180807101536.
Kumarasamy, V. et al. (2023) ‘Systematic Review and Meta-Analysis: Epidemiology of Human Blastocystis spp. Infection in Malaysia’, Tropical Medicine and Infectious Disease, 8(8). Available at: https://doi.org/10.3390/tropicalmed8080415
Lan, P.T. et al. (2021) ‘Phytochemical analysis and protective effect of ethanolic extract of Mimosa pudica Linn. on methylglyoxal-induced glucotoxicity’, Journal of Applied Pharmaceutical Science, 11(9), pp. 093–101. Available at: https://doi.org/10.7324/JAPS.2021.110911.
Maçin, S. et al. (2016) ‘Detection of parasites in children with chronic diarrhea’, Pediatrics International, 58(6), pp. 531–533. Available at: https://doi.org/10.1111/ped.12959.
Majeed, I. et al. (2021) ‘A comprehensive review of the ethnotraditional uses and biological and pharmacological potential of the genus mimosa’, International Journal of Molecular Sciences, 22(14). Available at: https://doi.org/10.3390/ijms22147463.
Mandal, A.K. et al. (2022a) ‘In Vitro Antioxidant and Antimicrobial Potency of Mimosa pudica of Nepalese Terai Region : Insight into L-Mimosine as an Antibacterial Agent’, 2022.
Mandal, A.K. et al. (2022b) ‘In Vitro Antioxidant and Antimicrobial Potency of Mimosa pudica of Nepalese Terai Region: Insight into L-Mimosine as an Antibacterial Agent’, Evidence-based Complementary and Alternative Medicine, 2022. Available at: https://doi.org/10.1155/2022/6790314.
Nair, P.V. and Nair, B.L.R. (2017) ‘Anti-inflammatory activity of hydroalcoholic extract of mimosa pudica whole plant in rats’, International Journal of Basic & Clinical Pharmacology, 6(3), p. 518. Available at: https://doi.org/10.18203/23192003.ijbcp20170473.
Patro, G. et al. (2016) ‘In vitro and in vivo Antioxidant evaluation and estimation of total phenolic, flavonoidal content of Mimosa pudica L’, Pharmacognosy Research, 8(1), pp. 22–28. Available at: https://doi.org/10.4103/0974-8490.171099.
Pawelec-Pęciak, O. et al. (2025) ‘The Role of Blastocystis spp. in the Etiology of Gastrointestinal and Autoimmune Diseases’, Pathogens, 14(4), pp. 1–20. Available at: https://doi.org/10.3390/pathogens14040313.
Popruk, S., Adao, D.E. V. and Rivera, W.L. (2021) ‘Epidemiology and subtype distribution of Blastocystis in humans: A review’, Infection, Genetics and Evolution, 95(September), p. 105085. Available at: https://doi.org/10.1016/j.meegid.2021.105085.
Queiroz, C.A.A. De et al. (2014) ‘Zinc treatment ameliorates diarrhea and intestinal inflammation in undernourished rats’, pp. 1–14.
Rana, K. et al. (2026) ‘From translational medicine to functional foods: Mechanistic insights and therapeutic applications of hormetic phytochemicals’, Food Chemistry Advances, 10(November 2025), p. 101204. Available at: https://doi.org/10.1016/j.focha.2025.101204
Rizwan, K. et al. (2022) ‘Phytochemistry and Diverse Pharmacology of Genus Mimosa: A Review’, Biomolecules, 12(1), pp. 1–31. Available at: https://doi.org/10.3390/biom12010083.
Roberts, T. et al. (2014) ‘Update on the pathogenic potential and treatment options for Blastocystis sp’, Gut Pathogens, 6(1), pp. 1–9. Available at: https://doi.org/10.1186/1757-4749-6-17.
Rojas-Velázquez, L. et al. (2022) ‘The regulatory function of Blastocystis spp. on the immune inflammatory response in the gut microbiome’, Frontiers in Cellular and Infection Microbiology, 12(August), pp. 1–9. Available at: https://doi.org/10.3389/fcimb.2022.967724.
Sardinha-Silva, A., Alves-Ferreira, E.V.C. and Grigg, M.E. (2022) ‘Intestinal immune responses to commensal and pathogenic protozoa’, Frontiers in Immunology, 13(September), pp. 1–17. Available at: https://doi.org/10.3389/fimmu.2022.963723.
Toghueo, R.M.K. et al. (2019) ‘Screening the MMV Open Access Pathogen box unveils novel and potent inhibitors of Amoebiasis agent: Entamoeba histolytica’, bioRxiv, pp. 1–34. Available at: https://doi.org/10.1101/723361.
Udonsom, R. et al. (2018) ‘Blastocystis infection and subtype distribution in humans, cattle, goats, and pigs in central and western Thailand’, Infection, Genetics and Evolution, 65, pp. 107–111. Available at: https://doi.org/10.1016/j.meegid.2018.07.007.
Vezza, T. et al. (2016) ‘Flavonoids in inflammatory bowel disease: A review’, Nutrients, 8(4). Available at: https://doi.org/10.3390/nu8040211.
Yim, S.K., Kim, S.W. and Lee, S.O.O.T. (2021) ‘Efficient Stool Collection Methods for Evaluating the Diarrhea Score in Mouse Diarrhea Models’, 2125, pp. 2115–2125. Available at: https://doi.org/10.21873/invivo.12481.
License
Copyright (c) 2026 Dzakiyyah Nafies Zirma, Eka Nofita, Nuzulia Irawati, Roza Silvia, Yanti Rahayu
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
